Report Overview

Saudi Arabia Clinical Nutrition Market is flourishing owing to increasing premature births, expanding the country's geriatric population, and rising birth rates along with the rising number of people needing treatment for malnutrition...

Saudi Arabia Clinical Nutrition Market - Industry Trends & Forecast Report 2028

Saudi Arabia Clinical Nutrition Market is predicted to grow at a CAGR of 10.3% during the forecast period (2022-2028). The rapid expansion of the market is predominantly due to the Shifting consumer preferences, rising health awareness, a growing millennial population, and an increase in supplementary income among consumers. Moreover, the convergence of major industry trends is creating new opportunities for industry key players. Also, the demand for nutritional analysis is being driven by changing lifestyles and the high prevalence of chronic diseases. The growing positive attitude toward sports nutrition would benefit the nutritional analysis market as well. Additionally, during the forecast period, the market is anticipated to rise due to the rising number of infants born with low body weights. For market participants, the rising demand for clinical nutrition in the pediatric category is anticipated to present attractive potential prospects.

Clinical Nutrition - Overview

Clinical nutrition is largely concerned with the prevention, diagnosis, and management of nutritional alterations in individuals who have chronic illnesses and disorders. In this context, the term "clinical" refers to the administration of patients, encompassing both inpatients and outpatients in hospitals as well as outpatients at clinics and in private practice. It mainly includes nutrition and dietetics as scientific disciplines. Additionally, therapeutic nutrition attempts to keep patients' energy levels in a healthy range while also giving them adequate amounts of nutrients like protein, vitamins, and minerals.

Saudi Arabia Clinical Nutrition Market Forecast and Trends

Growth Drivers

Infrastructure Improvements in Healthcare

Healthcare infrastructure, which makes use of clinical nutrition, is getting increasingly advanced in highly industrialized nations with high chronic illness prevalence. Moreover, personalization and targeted solutions innovation support market growth. Personalization is expanding in medical nutrition, as it is in other health and wellness categories, with innovations such as more targeted formulas (for example, Crohn's disease, Alzheimer's disease, and post-surgery recovery).

Increasing Geriatric Populations

In the upcoming years, the clinical nutrition market would experience considerable growth due to the rising incidence of chronic diseases like diabetes and cancer and the significant increase in the aged population. Elderly people are becoming more prevalent in many areas, making them vulnerable to chronic illnesses that call for clinical nutrition products during hospitalization and home care. The consequences of COVID-19 have made this worse. Frequently, elderly people experience appetite loss or digestive issues, necessitating enteral or parenteral vitamin supplementation. Over the coming years, it is anticipated that this capability would help the clinical nutrition sector globally.

Growing Clinical Nutrition Prescriptions

Because patients with chronic disorders lack important nutrients, the rise in chronic disorders has necessitated the use of clinical nutrition prescriptions. Furthermore, the growing obese population as a result of poor eating habits and a lack of exercise can hasten clinical nutrition market growth. Furthermore, the rapid increase in premature births, as well as the high birth rate, may benefit the country’s industry. Because of increased awareness and well-equipped facilities, premature death rates have decreased, resulting in significant market growth. All these factors boost the growth of the Saudi Arabia Clinical Nutrition Market during the forecast period (2022-2028).

Restraints

Stringent Regulations

Market expansion is predicted to be hampered by stringent regulations and worries about reimbursement. Pharmaceuticals are defined as products used in clinical nutrition. Because of this, makers are required to go by certain laws and guidelines set forth by regulatory bodies like the Saudi Food and Drug Authority (SFDA). Medicines and enteral products are comparable. They must therefore undergo protracted clinical trials to demonstrate their safety and effectiveness before being allowed for sale. Products for enteral nutrition must adhere to strict labeling guidelines, which include exhaustive supplement fact boxes. The market's expansion is expected to be constrained by this. Additionally, it is anticipated that the lack of knowledge about clinical nutrition in emerging regions may restrict the market growth.

Impact of COVID-19 on Saudi Arabia Clinical Nutrition Market

The ongoing COVID-19 pandemic and nationwide lockdowns imposed across the country has an impact on the clinical nutrition market. However, the need for nutritional treatment has increased, as patients with COVID-19 frequently require dietary supplements for a variety of micro and macronutrients. Additionally, the importance of adequate nutrition and dietary correlation during the COVID-19 pandemic has been widely addressed, according to research, not only as a means of preventing the onset of non-communicable diseases but also as a means of regulating the patients' inflammatory status. Moreover, not understanding the significance of diet in COVID-19 might also significantly affect the patient's prognosis. Hospitals and clinics may now better meet the needs of patients who need dietary supplements tailored to their particular diseases. These advances are anticipated to increase clinical nutrition management patient usage, enhancing industry statistics over the anticipated period.

Saudi Arabia Clinical Nutrition Market - By Nutrition Type

Based on the nutrition type, the Saudi Arabia Clinical Nutrition Market is segmented into Enteral Nutrition and Parental Nutrition. Parental nutrition is further subdivided into supplemental parenteral nutrition, total parenteral nutrition, all-in-one system, and multiple bottle system, while enteral nutrition is further subdivided into oral nutrition supplements and tube feeding. Because of the ease of administration, the enteral nutrition segment is expected to dominate the market during the forecast years. Furthermore, the widespread availability of products such as powders, capsules, soft gels, and liquids is expected to drive segment growth. All these factors propel the growth of the Saudi Arabia Clinical Nutrition Market during a forecast period (2022-2028).

Saudi Arabia Clinical Nutrition Market – By Route of Administration

Based on route of administration, the Saudi Arabia Clinical Nutrition Market is segmented into Oral, and Intravenous. Due to an increase in malnourished patients with malignancy, chronic disease, and/or anorexia, as well as an increase in the incidences of chronic diseases like cancer, gastrointestinal disorders, and metabolic disorders, the oral clinical nutrition market holds the largest share and is expected to maintain its dominance throughout the forecast period. All of these factors present lucrative growth opportunities for the Saudi Arabia Clinical Nutrition Market during the forecast period (2022-2028).

Saudi Arabia Clinical Nutrition Market - By Application

Based on application, the Saudi Arabia Clinical Nutrition Market is segmented into Metabolic Disorder, Eating Disorder, Stages of Development and Recovery, and Others. Among these, metabolic disorder dominates the market share. In the adult and elderly population, metabolic diseases are becoming more and more common. In many nations, diseases like diabetes have been a major issue. Moreover, the role of nutrition in managing metabolic illnesses is crucial. In cases of patchy intestinal dysmotility or symptomatic gastric atony seen in diabetic patients with autonomic neuropathy, clinical nutrition such as monosaturated fat and fiber is supplied to patients through jejunal feeding.

Saudi Arabia Clinical Nutrition Market – By End-User

Based on end-user, the Saudi Arabia Clinical Nutrition Market is segmented into infant & Child, Adults, and Elderly. The infant and child segment is expected to grow at a rapid pace from 2022 to 2028, owing to rising rates of malnutrition and preterm births nationwide. According to research, the mortality rate due to malnutrition in children under the age of five is around 45 percent. Poverty and overpopulation are two other factors that contribute to the spread of malnutrition in developing regions. Infants and children are the most vulnerable to the dangers. Clinical nutrients have been shown in studies to be effective in providing immediate nutritional support. Furthermore, several government and private organizations are collaborating to launch initiatives to combat infant malnutrition.

Competitive Landscape

The leading market players in the Saudi Arabia Clinical Nutrition Market are Nestle Saudi Arabia LLC, Abbott Saudi Arabia, Fresenius Medical Care Saudi Arabia Limited, Ideal Nutrition, Almarai Company, B Braun Saudi Arabia, BASF Saudi Arabia, and other prominent players.

The Saudi Arabia Clinical Nutrition Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

Scope of the Report

By Nutrition Type

• Enteral Nutrition
• Parental Nutrition

By Route Of Administration

• Oral
• Intravenous

By Substrate

• Energy
• Carbohydrates
• Lipids
• Protein
• Amino Acids
• Water & Electrolyte
• Dietary Fibre
• Antioxidants

By Application

• Metabolic Disorder
• Eating Disorder
• Stages Of Development and Recovery
• Others

By End-User

• Infant & Child
• Adults
• Elderly